Thank you, David1, for that kind introduction, and to MEDecision for hosting this wonderful event here today.
I am also pleased to see representatives of the Greater Philadelphia Chamber of Commerce, of Congressman Jim Gerlach’s office, and of Governor Edward Rendell’s office. Thank you for recognizing the wonderful asset that MEDecision is not only for this district but for Pennsylvania and the country as well. By way of background, the Technology Administration of the Department of Commerce is the agency of the United States government that seeks to maximize technology's contribution to economic growth, high-wage job creation, and the social well being of the United States. The Technology Administration carries out this mission by:
Finally, we recognize those companies that develop new technologies that transform their industries. I am pleased to be here today to recognize a leader in transforming health information technology, MEDecision, and its Patient Clinical Summary. MEDecision stands out as a driving force in the development of technologies which allow health care payers, providers and patients to work together for the benefit of all. Your products, particularly the Patient Clinical Summary, allow physicians to gain access to proper information about patients at the point of care. I was particularly impressed by the Blue Cross Blue Shield of Delaware/Christiana Care project which demonstrated, for the first time using an independent study, that the Patient Clinical Summary and the use of Payer data (1) improves patient care; and (2) reduces costs to both the payer and the provider. I am pleased to note that the Health Care Services Corporation health plan, and Blue Cross Blue Shield of Illinois, Texas, Oklahoma, and New Mexico see so much value in the Patient Clinical Summary that they are implementing it across all of their providers. Recognition of Excellence in Innovation
The U.S. Department of Commerce Technology Administration “Recognition of Excellence in Innovation” certificate is presented to recognize local and regional innovators throughout the United States. The recognition is given to individuals, teams, or companies doing business in the United States for the use of a new manufacturing technique, or for the introduction of new products into the market. I am pleased to be here today to present the U.S. Department of Commerce Technology Administration “Recognition of Excellence in Innovation” certificate to David St. Clair, Chief Executive Officer of MEDecision, for its Patient Clinical Summary. Congratulations David. ----
|